These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 16987999)

  • 1. Action of epoxyeicosatrienoic acids on cellular function.
    Spector AA; Norris AW
    Am J Physiol Cell Physiol; 2007 Mar; 292(3):C996-1012. PubMed ID: 16987999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arachidonic acid cytochrome P450 epoxygenase pathway.
    Spector AA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
    Spector AA; Fang X; Snyder GD; Weintraub NL
    Prog Lipid Res; 2004 Jan; 43(1):55-90. PubMed ID: 14636671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
    Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy.
    Noh MR; Jang HS; Salem FE; Ferrer FA; Kim J; Padanilam BJ
    Am J Physiol Renal Physiol; 2023 Feb; 324(2):F138-F151. PubMed ID: 36475868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
    Diani-Moore S; Ma Y; Gross SS; Rifkind AB
    Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular pharmacology of epoxyeicosatrienoic acids.
    Pfister SL; Gauthier KM; Campbell WB
    Adv Pharmacol; 2010; 60():27-59. PubMed ID: 21081214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARĪ³.
    Kim DH; Vanella L; Inoue K; Burgess A; Gotlinger K; Manthati VL; Koduru SR; Zeldin DC; Falck JR; Schwartzman ML; Abraham NG
    Stem Cells Dev; 2010 Dec; 19(12):1863-73. PubMed ID: 20412023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EET signaling in cancer.
    Panigrahy D; Greene ER; Pozzi A; Wang DW; Zeldin DC
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):525-40. PubMed ID: 22009066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
    Huang H; Weng J; Wang MH
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
    Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
    Karkhanis A; Tram NDT; Chan ECY
    Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells.
    Abukhashim M; Wiebe GJ; Seubert JM
    Cell Biol Toxicol; 2011 Oct; 27(5):321-32. PubMed ID: 21519968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
    Imig JD
    Prostaglandins Other Lipid Mediat; 2013; 104-105():2-7. PubMed ID: 23333581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
    Chen G; Xu R; Wang Y; Wang P; Zhao G; Xu X; Gruzdev A; Zeldin DC; Wang DW
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E563-75. PubMed ID: 22739108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
    Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
    Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexually dimorphic adaptation of cardiac function: roles of epoxyeicosatrienoic acid and peroxisome proliferator-activated receptors.
    Qin J; Le Y; Froogh G; Kandhi S; Jiang H; Luo M; Sun D; Huang A
    Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27354541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system.
    Larsen BT; Campbell WB; Gutterman DD
    Trends Pharmacol Sci; 2007 Jan; 28(1):32-8. PubMed ID: 17150260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of epoxyeicosatrienoic acids.
    Thomson SJ; Askari A; Bishop-Bailey D
    Int J Vasc Med; 2012; 2012():605101. PubMed ID: 22848834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.